GlassScriptPhysician profile
Emmett T Boyle
NPI 1811992654
$400.71
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $52.57 · 2022: $63.58 · 2023: $38.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $103.93 | 2019 | |
| Astellas Pharma US INC | $75.62 | 2019-2020 | |
| Blue Earth Diagnostics | $35.23 | 2019 | |
| Integra Lifesciences Corporation | $25.00 | 2022 | |
| Abbvie INC. | $22.82 | 2023 | Botox |
| Coloplast Corp | $17.45 | 2020 | |
| Halozyme INC | $15.88 | 2023 | |
| Procept Biorobotics Corporation | $14.81 | 2020 | |
| Neotract INC. | $14.58 | 2019 | |
| Teleflex LLC | $13.75 | 2022 | |
| Ferring Pharmaceuticals INC. | $13.06 | 2019 | |
| Urovant Sciences INC | $12.83 | 2022 | |
| Dendreon Pharmaceuticals LLC | $12.25 | 2019 | |
| Myovant Sciences INC. | $12.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.50 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$986.22 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emmett Boyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.